Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

13.3%

2 terminated out of 15 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

27%

4 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results85% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (4)
P 1 (2)
P 2 (4)
P 3 (3)
P 4 (1)

Trial Status

Completed11
Terminated2
Recruiting1
Not Yet Recruiting1

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07221786Not ApplicableRecruiting

Preoperative Opioid Tapering Before Spine Surgery

NCT06733649Not ApplicableNot Yet RecruitingPrimary

Treatment Education for Perinatal Women and Their Community Support

NCT01075971Phase 2CompletedPrimary

Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)

NCT00913484Phase 2Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

NCT00727675Not ApplicableCompleted

Chronic Pain and Opioid Dependence Assessment and Treatment

NCT01262261Phase 3CompletedPrimary

Re-Treatment Study of Probuphine in Opioid Addiction

NCT01114308Phase 3CompletedPrimary

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

NCT00772785Phase 3TerminatedPrimary

Study of Probuphine in Patients With Opioid Dependence

NCT00577005Phase 2Completed

Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients

NCT01806389CompletedPrimary

A Study of Breastfeeding in Buprenorphine Maintained Women

NCT00742170Phase 1CompletedPrimary

Transdermal Electroacupuncture for Opioid Detoxification

NCT00877591Phase 1CompletedPrimary

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

NCT00269607Phase 2TerminatedPrimary

Naltrexone Implants as Relapse Prevention

NCT00591617Not ApplicableCompletedPrimary

Optimizing Outcomes Using Suboxone for Opiate Dependence

NCT00955162Phase 4CompletedPrimary

Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")

Showing all 15 trials

Research Network

Activity Timeline